From the Department of Medicine (J.K.W., M.S., A.V., W.T., A.D., J.A.L., D.A.B., S.S., K.A., M.J.G.S., N.M.R., M.A.B., G.D., A.Z.T., D.R.S., M.A.F., F.H.), Department of Surgery (H.B.K., K.V.), Department of Cardiology (D.P., J.L., L.B.S., M.N.S.), Department of Neurology (M.J.R.), Department of Radiology (G.C.), and Department of Neurosurgery (E.R.S.), Boston Children's Hospital, Harvard Medical School, MA; Department of Pediatrics, Yale-New Haven Children's Hospital (J.K.W.) and Department of Genetics (S.M.M., R.P.L.), Yale School of Medicine, CT; Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Israel (A.V.); and Laboratory of Human Genetics and Genomics, The Rockefeller University, New York (R.P.L.).
Hypertension. 2018 Apr;71(4):691-699. doi: 10.1161/HYPERTENSIONAHA.117.10296. Epub 2018 Feb 26.
Midaortic syndrome (MAS) is a rare cause of severe childhood hypertension characterized by narrowing of the abdominal aorta in children and is associated with extensive vascular disease. It may occur as part of a genetic syndrome, such as neurofibromatosis, or as consequence of a pathological inflammatory disease. However, most cases are considered idiopathic. We hypothesized that in a high percentage of these patients, a monogenic cause of disease may be detected by evaluating whole exome sequencing data for mutations in 1 of 38 candidate genes previously described to cause vasculopathy. We studied a cohort of 36 individuals from 35 different families with MAS by exome sequencing. In 15 of 35 families (42.9%), we detected likely causal dominant mutations. In 15 of 35 (42.9%) families with MAS, whole exome sequencing revealed a mutation in one of the genes previously associated with vascular disease (, , , , and ). Ten of the 15 mutations have not previously been reported. This is the first report of , , or mutations in individuals with MAS. Mutations were detected in (6/15 families), (4/15 families), (3/15 families), and one family each for and Eight individuals had syndromic disease and 7 individuals had isolated MAS. Whole exome sequencing can provide conclusive molecular genetic diagnosis in a high fraction of individuals with syndromic or isolated MAS. Establishing an etiologic diagnosis may reveal genotype/phenotype correlations for MAS in the future and should, therefore, be performed routinely in MAS.
中主动脉综合征(MAS)是一种罕见的儿童重度高血压病因,其特征为儿童腹主动脉狭窄,并伴有广泛的血管疾病。它可能是神经纤维瘤等遗传性综合征的一部分,也可能是病理性炎症性疾病的后果。然而,大多数病例被认为是特发性的。我们假设,在这些患者中,很大一部分可能通过评估全外显子组测序数据中先前描述的导致血管病变的 38 个候选基因中的突变来发现单基因病因。我们通过外显子组测序研究了 36 名来自 35 个不同家庭的 MAS 患者。在 35 个家庭中的 15 个(42.9%)中,我们检测到可能的显性致病突变。在 35 个(42.9%)MAS 家庭中,全外显子组测序揭示了一个先前与血管疾病相关的基因中的突变(,,,, 和 )。其中 15 个突变中有 10 个以前没有报道过。这是首次在 MAS 患者中报告了 、 或 突变。在 (6/15 个家庭)、 (4/15 个家庭)、 (3/15 个家庭)和一个家庭中分别检测到了 、 、 和 突变。8 人患有综合征性疾病,7 人患有孤立性 MAS。全外显子组测序可以为综合征性或孤立性 MAS 的很大一部分个体提供明确的分子遗传学诊断。确定病因诊断将来可能会揭示 MAS 的基因型/表型相关性,因此,MAS 应常规进行。